CX Partners has made a partial exit from Mumbai-based Thyrocare Technologies Ltd by selling a portion of its stake to Emerging India Fund. According to sources familiar with the development, CX Partners has sold little over 2 per cent stake in the Dr A Velumani-promoted diagnostics chain, making over three times ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.